BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33990775)

  • 1. Genomic prediction of neoantigens: immunogenomics before NGS.
    Mardis ER
    Nat Rev Genet; 2021 Sep; 22(9):550-551. PubMed ID: 33990775
    [No Abstract]   [Full Text] [Related]  

  • 2. In Silico Prediction of Tumor Neoantigens with TIminer.
    Kirchmair A; Finotello F
    Methods Mol Biol; 2020; 2120():129-145. PubMed ID: 32124316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
    Lancaster EM; Jablons D; Kratz JR
    Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
    Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSNAD and TSNAdb: The Useful Toolkit for Clinical Application of Tumor-Specific Neoantigens.
    Wu J; Zhou Z
    Methods Mol Biol; 2023; 2673():167-174. PubMed ID: 37258913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer.
    Yin Q; Tang J; Zhu X
    Brief Funct Genomics; 2019 Mar; 18(2):119-128. PubMed ID: 29982317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Neoantigens for Personalised Immunotherapy.
    Pritchard AL
    BioDrugs; 2018 Apr; 32(2):99-109. PubMed ID: 29516371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Immunogenomics to Cancer.
    Liu XS; Mardis ER
    Cell; 2017 Feb; 168(4):600-612. PubMed ID: 28187283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction.
    Kodysh J; Rubinsteyn A
    Methods Mol Biol; 2020; 2120():147-160. PubMed ID: 32124317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic methods for cancer neoantigen prediction.
    Boegel S; Castle JC; Kodysh J; O'Donnell T; Rubinsteyn A
    Prog Mol Biol Transl Sci; 2019; 164():25-60. PubMed ID: 31383407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer immunotherapy targeting neoantigens derived from tumor-specific gene mutations].
    Sasada T
    Nihon Rinsho; 2017 Feb; 75(2):189-195. PubMed ID: 30562851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor neoantigens: building a framework for personalized cancer immunotherapy.
    Gubin MM; Artyomov MN; Mardis ER; Schreiber RD
    J Clin Invest; 2015 Sep; 125(9):3413-21. PubMed ID: 26258412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation position is an important determinant for predicting cancer neoantigens.
    Capietto AH; Jhunjhunwala S; Pollock SB; Lupardus P; Wong J; Hänsch L; Cevallos J; Chestnut Y; Fernandez A; Lounsbury N; Nozawa T; Singh M; Fan Z; de la Cruz CC; Phung QT; Taraborrelli L; Haley B; Lill JR; Mellman I; Bourgon R; Delamarre L
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31940002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing neoantigens for personalized cancer immunotherapy.
    Capietto AH; Jhunjhunwala S; Delamarre L
    Curr Opin Immunol; 2017 Jun; 46():58-65. PubMed ID: 28478383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumor immunology at the molecular divide.
    Finn OJ
    J Immunol; 2007 Mar; 178(5):2615-6. PubMed ID: 17312098
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoantigens in cancer immunotherapy.
    Schumacher TN; Schreiber RD
    Science; 2015 Apr; 348(6230):69-74. PubMed ID: 25838375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoantigens encoded in the cancer genome.
    Schumacher TN; Hacohen N
    Curr Opin Immunol; 2016 Aug; 41():98-103. PubMed ID: 27518850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer is a somatic cell pregnancy.
    Old LJ
    Cancer Immun; 2007 Nov; 7():19. PubMed ID: 17983204
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality.
    Radvanyi L
    Mol Ther; 2013 Aug; 21(8):1472-4. PubMed ID: 23903573
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.
    Polyakova A; Kuznetsova K; Moshkovskii S
    Expert Rev Proteomics; 2015; 12(5):533-41. PubMed ID: 26175083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.